Banco Bilbao Vizcaya Argentaria, S.A. Gilead Sciences, Inc. Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $9.82 Billion
- Q1 2025
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 564,533 shares of GILD stock, worth $61 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
564,533
Previous 559,884
0.83%
Holding current value
$61 Million
Previous $51.7 Million
22.31%
% of portfolio
0.64%
Previous 0.55%
Shares
22 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.43 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.9 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.78 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $135B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...